Quick Answer
Stereotaxis, Inc. reported Research And Development Expense of $9.38 million for the year ending 2025.
- Stereotaxis, Inc. showed a decrease of -3.9% in Research And Development Expense from 2024 to 2025.
- This data is from Stereotaxis, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Stereotaxis, Inc.'s Research And Development Expense has declined by 34.2%.
- Historical annual values: Fiscal year 2025: $9.38 million | Fiscal year 2024: $9.76 million | Fiscal year 2023: $10.27 million | Fiscal year 2022: $10.56 million | Fiscal year 2021: $10.20 million | Fiscal year 2020: $8.14 million | Fiscal year 2019: $9.02 million | Fiscal year 2018: $8.22 million | Fiscal year 2017: $6.70 million | Fiscal year 2016: $5.49 million | Fiscal year 2015: $6.25 million | Fiscal year 2014: $5.16 million | Fiscal year 2013: $5.67 million | Fiscal year 2012: $8.41 million | Fiscal year 2011: $12.89 million | Fiscal year 2010: $12.24 million | Fiscal year 2009: $14.26 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: